Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects
Clinical trial NCT03392116 · COMPLETED
Trial details
- NCT number
- NCT03392116
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2019-01-14
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.